Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Versus Intermittent Infusion of Human Antithrombin III Concentrate in the Immediate Postoperative Period After Liver Transplantation

NCT04219579 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04219579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Versus Intermittent Infusion of Human Antithrombin III Concentrate in the Immediate Postoperative Period After Liver Transplantation
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2020
Completion date
June 30, 2022
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant; complications